Skip to content
Alpha Cognition Inc. episode artwork

Feb 15, 2022 8 min

Alpha Cognition Inc.

from OTCQB Podcast Hosted by OTC Markets Group

Alpha Cognition Inc. (OTCQB: ACOGF) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and ALS. CEO Michael McFadden joins us to break down the types of neurodegenerative diseases that are targeted in the company's programs. View Podcast Transcript for Alpha Cognition

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Alpha Cognition Inc.

0:00 8:06

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OTCQB Podcast?

This episode is 8 minutes long.

When was this OTCQB Podcast episode published?

This episode was published on February 15, 2022.

Can I download this OTCQB Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.